24-Hydroxylase Deficiency and CYP24A1 Mutation Patient Registry
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT03478761
- Status
- Recruiting
Conditions
- 24-hydroxylase Deficiency
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Study Details
You are being asked to take part in this research registry because you or your family member is suspected to have a 24-hydroxylase deficiency.
Key Dates
- Start date
- Oct 19, 2017
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2030
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 600 participants (estimated)
Primary Outcome Measure
establish and maintain a registry of suspected and confirmed patients with 24 hydroxylase deficiency [ Time Frame: yearly ]
Central Contacts
- Barb M Seide, CCRP507-255-0387
- Rare Kidney Stone Consortium800-270-4637
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic | Rochester | Minnesota | 55905 |
Find similar trials in Rochester, MN
By research site